RSS   Newsletter   Contact   Advertise with us

Centogene appoints Sun Kim as interim chief business officer

Christian Fernsby | Berlin, Germany | May 16, 2020
CentogeneCentogene, a biotechnology company, announced that Sun Kim, current chief strategy and IR officer, will be interim chief business officer.
Prior to joining Centogene, Mr. Kim was Head of Corporate Strategy at Shire Plc.

Prior to joining Shire Plc, he worked in the Alcon division of Novartis in multiple roles, including General Manager of Singapore and Global Head of Strategy.

Mr. Kim also worked at Bausch and Lomb, leading its strategy function for the pharmaceutical business unit and the global generics franchise.

Prior to his experience in the pharmaceutical industry, he spent seven years as a management consultant at McKinsey and Company and A.T. Kearney.